Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 15 full-time employees. The company went IPO on 2018-02-14. The company has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.
Follow-Up Questions
Motus GI Holdings Inc (MOTS) の株価収益率はいくらですか?
Motus GI Holdings Inc の株価収益率は 0 です。
MOTS の株価パフォーマンスは?
MOTS の現在の価格は $0.0002 で、最終取引日から 0% decreased 変動しました。
Motus GI Holdings Inc の主な事業テーマや業界は?
Motus GI Holdings Inc は Health Care 業界、セクターは Health Care に属しています。